Development History_Development History_Qijian Bio-Pharmaceutical Co.,Ltd.

Home
About us 
Profiles Development Culture Honor Enterprise Style
Product 
Pharmaceutical products Medical beauty products
News 
Qijian News Industry news Social News Staff style Corporate Video
Cooperation
Contact 
Feedback Contact

关于我们





Homepage

Development History

2022-02-11

2005
Jilin Province Qijian Biotechnology Co., Ltd. was established
2022-02-11

2009
National Development and Reform Commission identified Qijian Bio as: National Biomedical Industry Base
2022-02-11

2010
Jilin Provincial Department of Science and Technology approved Qijian Bio: National High-tech Enterprise
2022-02-11

2015
Qijian Biological moved to a new location: No. 707 Chaofan Street, High-tech Industrial Development Zone, Changchun City
2022-02-11

2015
Qijian Bio's preparation workshop production line and biosynthesis workshop production line were completed and put into use
2022-02-11

2017
Qijian Bio's product "monosialotetrahexosylganglioside sodium (GM1)" was successfully registered in Uzbekistan, realized and exported, and is the first enterprise in Jilin Province to export injections
2022-02-11

2019
Qijian Biopharmaceutical API factory was successfully registered in the United States with the registration identification number "3010814382"
2022-02-11

2020
The "Recombinant Human Growth Hormone API" produced by Qijian Bio has been registered with the US FDA\DMF, and the record number is "33745"
2022-02-11

2021
Qijian Bio's "Drug Production License" was re-issued after on-site review by the regulatory department under the Jilin Provincial Drug Administration, and it is valid until April 22, 2026.
2022-02-11

2021
Qijian Bio has made a major breakthrough in the research and development of key transdermal technology used in medical beauty products using HGH analog peptides as raw materials, laying a good foundation for the company to expand the medical beauty industry.

新闻资讯

2005

Jilin Province Qijian Biotechnology Co., Ltd. was established

2022 02month

2009

National Development and Reform Commission identified Qijian Bio as: National Biomedical Industry Base

2022 02month

2010

Jilin Provincial Department of Science and Technology approved Qijian Bio: National High-tech Enterprise

2022 02month

2015

Qijian Biological moved to a new location: No. 707 Chaofan Street, High-tech Industrial Development Zone, Changchun City

2022 02month

2015

Qijian Bio's preparation workshop production line and biosynthesis workshop production line were completed and put into use

2022 02month

Qijian Bio's product "monosialotetrahexosylganglioside sodium (GM1)" was successfully registered in Uzbekistan, realized and exported, and is the first enterprise in Jilin Province to export injections

2022 02month

2019

Qijian Biopharmaceutical API factory was successfully registered in the United States with the registration identification number "3010814382"

2022 02month

2020

The "Recombinant Human Growth Hormone API" produced by Qijian Bio has been registered with the US FDA\DMF, and the record number is "33745"

2022 02month

2021

Qijian Bio's "Drug Production License" was re-issued after on-site review by the regulatory department under the Jilin Provincial Drug Administration, and it is valid until April 22, 2026.

2022 02month

2021

Qijian Bio has made a major breakthrough in the research and development of key transdermal technology used in medical beauty products using HGH analog peptides as raw materials, laying a good foundation for the company to expand the medical beauty industry.

2022 02month

Feedback

Mobile

0086-431-86561075

WeChat

TOP

Username used for comment:

客户留言

Description:

* Message content：

Name：

Mobile：

Add：

WeChat

ADD： No.707 Chaofan street, High-Tech Industrial Development Zone, Changchun City, Jilin province, China
Service Hotline：0086-431-86561075
Fax：0086-431-88794098
Email：export@qijianbio.com

Member Login | Mailbox

搜索